ATC code - L01EB
SpainEpidermal growth factor receptor (egfr) tyrosine kinase inhibitors
- L01EB01 Gefitinib 2 drugs
- L01EB02 Erlotinib 11 drugs
- L01EB03 Afatinib 3 drugs
- L01EB04 Osimertinib 2 drugs
- L01EB07 Dacomitinib 3 drugs
- L01EB09 2 drugs
Drugs with code L01EB
-
Form: tablets, film-coated
Active substance Dosage erlotinib hydrochloride 163,9 mg ATC code: L01E, L01EB, L01EB02
Manufacturer: Sandoz Farmaceutica S.A.
-
Form: tablets, film-coated
Active substance Dosage erlotinib hydrochloride 27,32 mg ATC code: L01E, L01EB, L01EB02
Manufacturer: Sandoz Farmaceutica S.A.
-
Form: tablets, film-coated
Active substance Dosage erlotinib hydrochloride Igual a 109.267 mg mg ATC code: L01E, L01EB, L01EB02
Manufacturer: Tarbis Farma S.L.
-
Form: tablets, film-coated
Active substance Dosage erlotinib hydrochloride 163.900 mg ATC code: L01E, L01EB, L01EB02
Manufacturer: Tarbis Farma S.L.
-
Form: tablets, film-coated
Active substance Dosage erlotinib hydrochloride Igual a 27.317 mg mg ATC code: L01E, L01EB, L01EB02
Manufacturer: Tarbis Farma S.L.
-
Form: tablets, film-coated
Active substance Dosage erlotinib hydrochloride 109,28 mg ATC code: L01E, L01EB, L01EB02
Manufacturer: Teva B.V.
-
Form: tablets, film-coated
Active substance Dosage erlotinib hydrochloride 163,93 mg ATC code: L01E, L01EB, L01EB02
Manufacturer: Teva B.V.
-
Form: tablets, film-coated
Active substance Dosage erlotinib hydrochloride 27,32 mg ATC code: L01E, L01EB, L01EB02
Manufacturer: Teva B.V.
-
Form: tablets, film-coated
Active substance Dosage gefitinib 250 mg ATC code: L01E, L01EB, L01EB01
Manufacturer: Sandoz Farmaceutica S.A.
-
Form: tablets, film-coated
Active substance Dosage gefitinib 250 mg ATC code: L01E, L01EB, L01EB01
Manufacturer: Teva B.V.
-
Form: tablets, film-coated
Active substance Dosage afatinib 20 mg ATC code: L01E, L01EB, L01EB03
Manufacturer: Boehringer Ingelheim International Gmbh
-
Form: tablets, film-coated
Active substance Dosage afatinib 30 mg ATC code: L01E, L01EB, L01EB03
Manufacturer: Boehringer Ingelheim International Gmbh
-
Form: tablets, film-coated
Active substance Dosage afatinib 40 mg ATC code: L01E, L01EB, L01EB03
Manufacturer: Boehringer Ingelheim International Gmbh
-
Form: tablets, film-coated
Active substance Dosage lazertinib 240 mg ATC code: L01E, L01EB, L01EB09
Manufacturer: Janssen-Cilag International N.V
-
Form: tablets, film-coated
Active substance Dosage lazertinib 80 mg ATC code: L01E, L01EB, L01EB09
Manufacturer: Janssen-Cilag International N.V
-
Form: tablets, film-coated
Active substance Dosage osimertinib mesilate 47,7 mg ATC code: L01E, L01EB, L01EB04
Manufacturer: Astrazeneca Ab
-
Form: tablets, film-coated
Active substance Dosage osimertinib mesilate 95,4 mg ATC code: L01E, L01EB, L01EB04
Manufacturer: Astrazeneca Ab
-
Form: tablets, film-coated
Active substance Dosage erlotinib 100 mg ATC code: L01E, L01EB, L01EB02
Manufacturer: Cheplapharm Registration Gmbh
-
Form: tablets, film-coated
Active substance Dosage erlotinib 150 mg ATC code: L01E, L01EB, L01EB02
Manufacturer: Cheplapharm Registration Gmbh
-
Form: tablets, film-coated
Active substance Dosage erlotinib 25 mg ATC code: L01E, L01EB, L01EB02
Manufacturer: Cheplapharm Registration Gmbh
-
Form: tablets, film-coated
Active substance Dosage dacomitinib monohydrate 15.576 mg ATC code: L01E, L01EB, L01EB07
Manufacturer: Pfizer Europe Ma Eeig
-
Form: tablets, film-coated
Active substance Dosage dacomitinib monohydrate 31.153 mg ATC code: L01E, L01EB, L01EB07
Manufacturer: Pfizer Europe Ma Eeig
-
Form: tablets, film-coated
Active substance Dosage dacomitinib monohydrate 46.729 mg ATC code: L01E, L01EB, L01EB07
Manufacturer: Pfizer Europe Ma Eeig